Chen Ruoyu
SEC insider (Form 3/4/5 filer). CIK 0001982080. Chief Financial Officer at GYRE THERAPEUTICS, INC. (GYRE). 1 reported Form 4/5 transaction since Sep 2024; latest on Jan 7, 2026. Located in SAN DIEGO, CA.
Companies Chen Ruoyu has filed insider reports for
- GYRE THERAPEUTICS, INC. (GYRE): Officer, Chief Financial Officer
Chen Ruoyu
CIK: 0001982080
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
GYRE
GYRE THERAPEUTICS, INC.
Officer